Evidence map›Paper›PMID 36847073›Full record

ArticleEuropean journal of heart failure2023

Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction.

Emma K Gard, Anna L Beale, Fernando Telles, Frank E Silvestry, Thomas Hanff, Scott L Hummel, Sheldon E Litwin, Mark C Petrie, Sanjiv J Shah, Barry A Borlaug and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Subtle echocardiographic markers of CAD: looking beyond the LV ejection fraction in stable angina patients.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  5. Article
  6. 2024 update in heart failure.ESC heart failure · 2025
    Review
  7. Article
  8. Article
  9. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.European respiratory review : an official journal of the European Respiratory Society · 2024
    Article
  10. The role of uromodulin in cardiovascular disease: a review.Frontiers in cardiovascular medicine · 2024
    Review
  11. Active left atrial ejection fraction as a non-invasive marker in pulmonary hypertension secondary to heart failure.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2024
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

Emma K GardAlfred Hospital, Melbourne, Victoria, Australia.
Anna L BealeAlfred Hospital, Melbourne, Victoria, Australia.
Fernando TellesHeart Failure Research Group, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
Frank E SilvestryHospital of the University of Pennsylvania, Philadelphia, PA, USA.
Thomas HanffHospital of the University of Pennsylvania, Philadelphia, PA, USA.
Scott L HummelUniversity of Michigan and VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Sheldon E LitwinMedical University of South Carolina, Charleston, SC, USA.
Mark C PetrieUniversity of Glasgow, Glasgow, UK.
Sanjiv J ShahNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Barry A BorlaugMayo Clinic College of Medicine, Rochester, MN, USA.
Dan BurkhoffCardiovascular Research Foundation, New York, NY, USA.
Jan KomtebeddeCorvia Medical, Boston, MA, USA.
David M KayeAlfred Hospital, Melbourne, Victoria, Australia.
Shane NanayakkaraAlfred Hospital, Melbourne, Victoria, Australia.
Baker Heart and Diabetes Institute · AUHospital of the University of Pennsylvania · USThe Alfred Hospital · AUCardiovascular Research Foundation · USCorvia Medical (United States) · USMayo Clinic · USMedical University of South Carolina · USNorthwestern University · USUniversity of Glasgow · GBUniversity of Michigan · US

Funding

Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and PhenomicsR01HL127028 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BERTONI, ALAIN GERALD, SHAH, SANJIV J · 2015 to 2018
$6.5M
Study of Cardiac Mechanics in Systemic HypertensionR01HL107577 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHAH, SANJIV J · 2011 to 2019
$4.1M
NHLBI NIH HHS R01 HL107577NHLBI NIH HHS R01 HL127028
6 · The paper itself

Abstract

aimsElevated left atrial (LA) pressure is a pathophysiologic hallmark of heart failure with preserved ejection fraction (HFpEF). Chronically elevated LA pressure leads to LA enlargement, which may impair LA function and increase pulmonary pressures. We sought to evaluate the relationship between LA volume and pulmonary arterial haemodynamics in patients with HFpEF. METHODS AND

resultsData from 85 patients (aged 69 ± 8 years) who underwent exercise right heart catheterization and echocardiography were retrospectively analysed. All had symptoms of heart failure, left ventricular ejection fraction ≥50% and haemodynamic features of HFpEF. Patients were divided into LA volume index-based tertiles (≤34 ml/m

conclusionIncreasing LA volume may be associated with more advanced pulmonary vascular disease in HFpEF, featuring higher PVR and pulmonary pressures. Reduced LA function, worse at increasing LA volumes, is associated with a disrupted PVR-compliance relationship, further augmenting impaired pulmonary haemodynamics.

Indexed as

Atrial FibrillationHeart FailureVascular DiseasesHumansRetrospective StudiesStroke VolumeVentricular Function, LeftCardiac catheterizationEchocardiographyExercise haemodynamicsHeart failure with preserved ejection fractionLeft atriumPulmonary hypertension

Identifiers

PMID36847073
PMCPMC10625803
OpenAlexW4322500058

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.